Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (4): 413-418.doi: 10.3969/j.issn.1000-6621.2021.04.020

• 短篇论著 • 上一篇    下一篇

抗结核药品导致严重骨髓抑制一例并文献复习

刘鑫, 郭乐, 仵倩红()   

  1. 710100 西安,陕西省结核病防治院
  • 收稿日期:2020-12-24 出版日期:2021-04-10 发布日期:2021-04-09
  • 通信作者: 仵倩红 E-mail:15902969531@126.com

A case of severe myelosuppression caused by anti-tuberculosis drugs and literature review on this issue

LIU Xin, GUO Le, WU Qian-hong()   

  1. Shaanxi Provincial Tuberculosis Prevention and Control Institute, Xi’an 710100, China
  • Received:2020-12-24 Online:2021-04-10 Published:2021-04-09
  • Contact: WU Qian-hong E-mail:15902969531@126.com

摘要:

抗结核药品是引起骨髓抑制的危险因素,严重者可导致患者死亡。本文作者报道了1例与使用抗结核药品相关的骨髓抑制并导致死亡的患者。患者为女性,24岁,以“发现双侧颈部包块1个月余,经外院穿刺病理诊断为颈部淋巴结结核”住院治疗,入院后颈部包块脓液经结核分枝杆菌药物敏感性试验(MTB-DST)证实为耐多药结核病,入院常规行血液检查未见异常后给予初治抗结核治疗(3H-R-Z-E/12H-R),全血细胞从最初的仅粒系细胞轻度降低,逐步发展至重度降低,最终红系、粒系、巨核系细胞均严重降低,从而继发感染性休克;患者被积极抢救后失败,最终死亡。作者通过复习相关文献,讨论了抗结核药品引起骨髓抑制的发病机制、临床表现、诊断及治疗方法,提醒临床医生了解抗结核药品引起的血液系统不良反应及其严重性,尽早明确原因并采取必要的干预措施。

关键词: 抗结核药, 结核,抗多种药物性, 骨髓疾病, 死亡, 综述文献(主题)

Abstract:

Anti-tuberculosis drug is a risk factor for causing bone marrow suppression, which can lead to death in severe cases. This article reported a patient who got bone marrow suppression caused by the use of anti-tuberculosis drugs and died. The authors also did a literature review regarding to this issue. The patient was female, 24 years old. She was found to have bilateral neck masses for more than 1 month and diagnosed as cervical lymph node tuberculosis by puncture biopsy in another hospital before she came to our hospital. After admission, she was confirmed as multidrug-resistant tuberculosis (MDR-TB) by Mycobacterium tuberculosis drug susceptible test (MTB-DST) using the pus obtained from her neck mass. The routine blood examinations were performed for her and the results were normal, and then the initial treatment regimen of anti-tuberculosis (3H-R-Z-E/12H-R) was given to this patient. After she received the treatment, the granulocyte cells were starting to drop slightly and gradually progressed to severe reduction, and then further progressed to severe reductions of the erythroid, granulocyte and megakaryocyte cells. The patient eventually died of infectious shock and failure to resuscitate. By reviewing the relevant publications, the authors did discussions on pathogenesis, clinical manifestations, diagnosis and treatment of bone marrow suppression caused by anti-tuberculosis drugs in this article, aimed to remind clinicians to understand the adverse reactions in blood system caused by anti-tuberculosis drugs and their severity, and to emphasize that the causes of the abnormal blood test results should be identified as soon as possible and the effective intervention measures should be taken soon.

Key words: Antitubercular agents, Tuberculosis, multidrug-resistant, Bone marrow diseases, Death, Review literature as topic